Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancerP Harter, F Trillsch, A Okamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)Husam A Alqaisi, David E Cohn, Jing-Yi Chern, et al.
Nature Communications|August 27, 2021
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivityS Y Cindy Yang, Scott C Lien, Ben X Wang, et al.
NPJ Precision Oncology|February 13, 2026
Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumabEric Y Stutheit-Zhao, Yongqi Zhong, Collin A Melton, et al.
European Journal of Human Genetics : EJHG|January 29, 2026
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortiumKirsten M Farncombe, Julia A Sobotka, Melyssa Aronson, et al.
The New England Journal of Medicine|February 9, 2022
Survival with Cemiplimab in Recurrent Cervical CancerKrishnansu S Tewari, Bradley J Monk, Ignace Vergote, et al.
Journal for Immunotherapy of Cancer|March 15, 2019
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based OutreachGoli Samimi, Marcus Q Bernardini, Lawrence C Brody, et al.
Nature Reviews. Cancer|April 13, 2026
Rethinking ovarian cancer III: the past decade and future directionsFrances R Balkwill, Céline M Laumont, Nikki Burdett, et al.
Annals of Intensive Care|November 19, 2025
Further analysis and refinements of the perceived stressors in intensive care units (PS-ICU) scale: a French nation-wide cross-sectional multicentre studyFlorent Lheureux, Maxime Jollivet, Juliette Chiron, et al.
Pageof 31